🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/07/1996 | 49,13 | 49,13 | 43,98 | 44,92 | -7,69% | 10,48% | 36.415 |
| 22/07/1996 | 47,72 | 49,13 | 47,26 | 48,66 | -0,95% | 3,92% | 8.576 |
| 19/07/1996 | 48,66 | 50,53 | 47,26 | 49,13 | +2,94% | 6,73% | 31.980 |
| 18/07/1996 | 46,79 | 50,06 | 43,98 | 47,72 | +6,25% | 13,00% | 56.586 |
| 17/07/1996 | 44,92 | 44,92 | 42,11 | 44,92 | +6,67% | 6,25% | 59.151 |
| 16/07/1996 | 42,11 | 43,98 | 38,83 | 42,11 | -4,26% | 12,22% | 108.363 |
| 15/07/1996 | 45,85 | 46,32 | 42,11 | 43,98 | -4,08% | 9,18% | 44.590 |
| 12/07/1996 | 44,92 | 46,79 | 43,98 | 45,85 | +2,08% | 6,25% | 52.659 |
| 11/07/1996 | 48,66 | 50,53 | 44,92 | 44,92 | -8,57% | 11,54% | 85.814 |
| 10/07/1996 | 53,34 | 53,34 | 48,66 | 49,13 | -6,25% | 8,77% | 57.200 |
| 09/07/1996 | 53,81 | 54,27 | 52,40 | 52,40 | -2,61% | 3,48% | 22.121 |
| 08/07/1996 | 53,34 | 56,14 | 51,93 | 53,81 | -0,86% | 7,89% | 45.392 |
| 05/07/1996 | 56,14 | 56,14 | 53,34 | 54,27 | -2,52% | 5,00% | 10.820 |
| 03/07/1996 | 57,08 | 58,95 | 53,34 | 55,68 | -2,46% | 9,84% | 42.453 |
| 02/07/1996 | 58,02 | 58,95 | 57,08 | 57,08 | -3,17% | 3,23% | 30.217 |
| 01/07/1996 | 59,89 | 59,89 | 57,55 | 58,95 | -5,26% | 3,91% | 28.053 |
| 28/06/1996 | 53,81 | 64,10 | 52,40 | 62,23 | +18,75% | 21,74% | 238.794 |
| 27/06/1996 | 51,47 | 53,81 | 51,00 | 52,40 | +0,00% | 5,45% | 34.732 |
| 26/06/1996 | 52,87 | 53,81 | 51,00 | 52,40 | -2,61% | 5,31% | 50.869 |
| 25/06/1996 | 55,21 | 55,21 | 52,87 | 53,81 | -2,54% | 4,24% | 27.064 |
| 24/06/1996 | 53,34 | 55,21 | 52,40 | 55,21 | +5,36% | 5,26% | 30.644 |
| 21/06/1996 | 50,53 | 53,34 | 50,53 | 52,40 | +2,75% | 5,56% | 38.125 |
| 20/06/1996 | 52,40 | 54,27 | 50,53 | 51,00 | -6,03% | 7,14% | 57.548 |
| 19/06/1996 | 56,14 | 56,14 | 52,40 | 54,27 | -1,70% | 6,67% | 61.635 |
| 18/06/1996 | 56,14 | 56,14 | 55,21 | 55,21 | -2,48% | 1,67% | 32.835 |
| 17/06/1996 | 56,14 | 56,61 | 55,68 | 56,61 | +0,83% | 1,67% | 20.812 |
| 14/06/1996 | 56,14 | 56,61 | 56,14 | 56,14 | +0,00% | 0,83% | 23.831 |
| 13/06/1996 | 58,02 | 58,95 | 54,74 | 56,14 | -4,76% | 7,26% | 75.982 |
| 12/06/1996 | 62,23 | 62,23 | 58,02 | 58,95 | -4,55% | 6,77% | 55.063 |
| 11/06/1996 | 62,69 | 63,63 | 60,82 | 61,76 | -3,65% | 4,48% | 45.285 |